{"nct_id":"NCT03400033","title":"Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)","status":"COMPLETED","status_verified_date":"2021-06","start_date":"2018-09-05","start_date_type":"ACTUAL","primary_completion_date":"2020-06-19","primary_completion_date_type":"ACTUAL","completion_date":"2020-06-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}